Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2013 (2013), Article ID 750814, 6 pages
http://dx.doi.org/10.1155/2013/750814
Research Article

Susceptibility for Lupus Nephritis by Low Copy Number of the FCGR3B Gene Is Linked to Increased Levels of Pathogenic Autoantibodies

1Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø, 9037 Tromsø, Norway
2Department of Rheumatology, University Hospital Northern Norway, P.O. Box 14, 9038 Tromsø, Norway
3Department of Rheumatology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, SA 5020, Australia
4Division of Medicine, University of Adelaide, Adelaide, SA 5000, Australia

Received 8 May 2013; Accepted 3 June 2013

Academic Editor: Giuseppe Murdaca

Copyright © 2013 Johannes C. Nossent et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Guescini, D. Sisti, M. B. L. Rocchi, L. Stocchi, and V. Stocchi, “A new real-time PCR method to overcome significant quantitative inaccuracy due to slight amplification inhibition,” BMC Bioinformatics, vol. 9, article 326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Kontaki and D. T. Boumpas, “Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids,” Journal of Autoimmunity, vol. 35, no. 3, pp. 206–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lauterbach, P. O'Donnell, K. Asano, and T. N. Mayadas, “Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes,” Journal of Leukocyte Biology, vol. 83, no. 6, pp. 1423–1430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Zhou, J. Lv, L. Yu et al., “FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese,” Nephrology Dialysis Transplantation, vol. 25, no. 1, pp. 97–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zhou, J. Lv, D. Bu et al., “Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease,” International Immunology, vol. 22, no. 1, pp. 45–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. B. Niewold, T. L. Rivera, J. P. Buyon, and M. K. Crow, “Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus,” Arthritis and Rheumatism, vol. 58, no. 2, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. L. Armour, C. S. Smith, and M. R. Clark, “Expression of human FcγRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding,” Journal of Immunological Methods, vol. 354, no. 1-2, pp. 20–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. W. Choy, S. R. Setlur, C. Lee, and T. K. Lau, “The impact of human copy number variation on a new era of genetic testing,” BJOG, vol. 117, no. 4, pp. 391–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. Schrider and M. W. Hahn, “Gene copy-number polymorphism in nature,” Proceedings of the Royal Society B, vol. 277, no. 1698, pp. 3213–3221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. McKinney and T. R. Merriman, “Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes,” Human Molecular Genetics, vol. 21, no. 10, pp. 2370–2376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. N. Mayadas, G. C. Tsokos, and N. Tsuboi, “Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury,” Circulation, vol. 120, no. 20, pp. 2012–2024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. A. Niederer, M. R. Clatworthy, L. C. Willcocks, and K. G. Smith, “FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1183, pp. 69–88, 2010. View at Google Scholar
  14. X. Li, T. S. Ptacek, E. E. Brown, and J. C. Edberg, “Fcγ receptors: structure, function and role as genetic risk factors in SLE,” Genes and Immunity, vol. 10, no. 5, pp. 380–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. A. Niederer, L. C. Willcocks, T. F. Rayner et al., “Copy number, linkage disequilibrium and disease association in the FCGR locus,” Human Molecular Genetics, vol. 19, no. 16, pp. 3282–3294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Lv, Y. Yang, X. Zhou et al., “FCGR3B copy number variation is not associated with lupus nephritis in a Chinese population,” Lupus, vol. 19, no. 2, pp. 158–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Fanciulli, P. J. Norsworthy, E. Petretto et al., “FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity,” Nature Genetics, vol. 39, no. 6, pp. 721–723, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Molokhia, M. Fanciulli, E. Petretto et al., “FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans,” Rheumatology, vol. 50, no. 7, pp. 1206–1210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. J. Aitman, R. Dong, T. J. Vyse et al., “Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans,” Nature, vol. 439, no. 7078, pp. 851–855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. O. Eilertsen, A. Becker-Merok, and J. C. Nossent, “The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management,” The Journal of Rheumatology, vol. 36, no. 3, pp. 552–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R Development Core Team, R: A Language and Environment for Statistical Computing, R Development Core Team, Vienna, Austria, 2008.
  22. C. Ritz and A. Spiess, “qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis,” Bioinformatics, vol. 24, no. 13, pp. 1549–1551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. W. B. Breunis, E. van Mirre, J. Geissler et al., “Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B,” Human Mutation, vol. 30, no. 5, pp. E640–E650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. W. Graf, S. Lester, J. C. Nossent et al., “Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis,” Arthritis Research and Therapy, vol. 14, no. 1, article R28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. V. Wain and M. D. Tobin, “Copy number variation,” Methods in Molecular Biology, vol. 713, pp. 167–183, 2011. View at Google Scholar · View at Scopus
  26. M. P. L. Calus, D. J. De Koning, and C. S. Haley, “Including copy number variation in association studies to predict genotypic values,” Genetics Research, vol. 92, no. 2, pp. 115–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Lee and S. W. Scherer, “The clinical context of copy number variation in the human genome,” Expert Reviews in Molecular Medicine, vol. 12, e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Yang, Q. Zhou, D. J. Chen, H. Jiang, Y. Y. Mao, and J. H. Chen, “The single nucleotide polymorphisms gene but not the copy number variation of Fcgr3B is associated with lupus nephritis in Chinese people,” Lupus, vol. 19, no. 5, pp. 662–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. L. Morris, A. L. Roberts, A. S. Witherden et al., “Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus,” European Journal of Human Genetics, vol. 18, no. 9, pp. 1027–1031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Cullere, M. Lauterbach, N. Tsuboi, and T. N. Mayadas, “Neutrophil-selective CD18 silencing using RNA interference in vivo,” Blood, vol. 111, no. 7, pp. 3591–3598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Tsuboi, K. Asano, M. Lauterbach, and T. N. Mayadas, “Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases,” Immunity, vol. 28, no. 6, pp. 833–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. N. Hogben and M. E. Devey, “Studies on rheumatoid factor: i. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice,” Clinical and Experimental Immunology, vol. 66, no. 3, pp. 648–653, 1986. View at Google Scholar · View at Scopus
  33. L. Marois, G. Paré, M. Vaillancourt, E. Rollet-Labelle, and P. H. Naccache, “FcγRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils,” The Journal of Biological Chemistry, vol. 286, no. 5, pp. 3509–3519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. St-Onge, S. Lagarde, C. Laflamme et al., “Proteinase-activated receptor-2 up-regulation by Fcγ-receptor activation in human neutrophils,” The FASEB Journal, vol. 24, no. 6, pp. 2116–2125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. C. Willcocks, P. A. Lyons, M. R. Clatworthy et al., “Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake,” Journal of Experimental Medicine, vol. 205, no. 7, pp. 1573–1582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Riboldi, M. Gerosa, G. Moroni et al., “Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?” Autoimmunity, vol. 38, no. 1, pp. 39–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Stokol, P. O'Donnell, L. Xiao et al., “C1q governs deposition of circulating immune complexes and leukocyte Fcγ receptors mediate subsequent neutrophil recruitment,” Journal of Experimental Medicine, vol. 200, no. 7, pp. 835–846, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. E. Devey and D. N. Hogben, “Rheumatoid factor and immune complexes,” Monographs in Allergy, vol. 26, pp. 230–239, 1989. View at Google Scholar · View at Scopus
  39. C. McKinney, M. Fanciulli, M. E. Merriman et al., “Association of variation in Fcγ receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples,” Annals of the Rheumatic Diseases, vol. 69, no. 9, pp. 1711–1716, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. C. Nossent, M. Rischmueller, and S. Lester, “Low copy number of the Fc-Gamma receptor 3B gene FCGR3B is a risk factor for primary Sjogren's syndrome,” The Journal of Rheumatology, vol. 39, no. 11, pp. 2142–2147, 2012. View at Google Scholar
  41. M. Mamtani, J.-M. Anaya, W. He, and S. K. Ahuja, “Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases,” Genes and Immunity, vol. 11, no. 2, pp. 155–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Janwityanuchit, O. Verasertniyom, M. Vanichapuntu, and M. Vatanasuk, “Anti-Sm: its predictive value in systemic lupus erythematosus,” Clinical Rheumatology, vol. 12, no. 3, pp. 350–353, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. E. J. Hollox, J. Detering, and T. Dehnugara, “An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus,” Human Mutation, vol. 30, no. 3, pp. 477–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Lloyd and P. H. Schur, “Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE),” Medicine, vol. 60, no. 3, pp. 208–217, 1981. View at Google Scholar · View at Scopus
  45. A. J. G. Swaak, J. Groenwold, A. Hannema, and C. E. Hack, “Correlation of disease activity with circulating immune complexes (C(1Q)bA) and complement breakdown products (C(3D)) in patients with systemic lupus erythematosus. A prospective study,” Rheumatology International, vol. 5, no. 5, pp. 215–220, 1985. View at Google Scholar · View at Scopus
  46. V. Agnello, “Immune complex assays in rheumatic diseases,” Human Pathology, vol. 14, no. 4, pp. 343–349, 1983. View at Google Scholar · View at Scopus